Advertisement
Screener

MILESTONE SCIENTIFIC INC. (MLSS) Overview

MILESTONE SCIENTIFIC INC. (MLSS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.01; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.01; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.01; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.02; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.24$0.28$0.34$0.40$0.48$0.582025-09-292026-09-29$0.24$0.39$0.64$1.05$1.73$2.852021-09-292026-09-29$0.24$0.44$0.80$1.46$2.68$4.902016-09-292026-09-29$0.19$0.36$0.70$1.34$2.56$4.902006-09-292026-09-29$0.19$0.65$2.23$7.63$26.11$89.391995-11-032026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.41
Previous close
$0.41
Change
$0.00
Change (%)
0.00%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

MLSS
+51.85%
S&P 500
(m)

1 year

MLSS
-10.87%
S&P 500
(m)

3 years

MLSS
-55.43%
S&P 500
(m)

5 years

MLSS
-75.60%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.01

-0.10-0.030.040.100.1731 Mar 2025: estimate (m); actual -0.0231 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.0230 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0130 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0131 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0130 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.01(m)(m)
1 Jan 202631 Mar 2026(m)-0.01(m)(m)
1 Jul 202530 Sept 2025(m)-0.01(m)(m)
1 Apr 202530 Jun 2025(m)-0.02(m)(m)
1 Jan 202531 Mar 2025(m)-0.02(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.07

-0.24-0.15-0.060.030.1231 Dec 2019: estimate (m); actual -0.1631 Dec 2019(m)31 Dec 2020: estimate (m); actual -0.1231 Dec 2020(m)31 Dec 2021: estimate (m); actual -0.1031 Dec 2021(m)31 Dec 2024: estimate (m); actual -0.0631 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.0731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.07(m)(m)
1 Jan 202431 Dec 2024(m)-0.06(m)(m)
1 Jan 202131 Dec 2021(m)-0.10(m)(m)
1 Jan 202031 Dec 2020(m)-0.12(m)(m)
1 Jan 201931 Dec 2019(m)-0.16(m)(m)

Revenue vs. Earnings

USD

31 Mar 2014 ■ Revenue 2.62M ■ Earnings 0.19M — Profit margin 7.43%

-0.31M5.1%0.77M6.2%1.85M7.3%2.94M8.4%31 Mar 2013: revenue 2.49M; earnings 0.15M; profit margin 6.06%31 Mar 201331 Mar 2014: revenue 2.62M; earnings 0.19M; profit margin 7.43%31 Mar 2014

No complete retained periods.

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.41(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.41High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning MLSS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Mar 2014.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$1.51M
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
77.34K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.50%*
Total return · month
-18.00%*
Total return · quarter
28.13%*
Total return · half year
51.85%*
Total return · year to date
51.85%*
Total return · 1 year
-10.87%*
Total return · 3 years
-55.43%*
Total return · 5 years
-75.60%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

MILESTONE SCIENTIFIC INC. Overview

View more →

(m)

(m)

SEC CIK
855683
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
220 SOUTH ORANGE AVENUE, LIVINGSTON, New Jersey, 07039, United States
Fiscal year end
1231
Phone
(973) 535-2717

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifeward Ltd. (LFWD)$0.021B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
ENvue Medical, Inc. (FEED)United States$0.011B
MYOMO, INC. (MYO)United States$0.065B-2.85
Bone Biologics Corp (BBLG)United States$0.001B
LogicMark, Inc. (LGMK)United States$0.000B
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B